The Solution to a ‘Common and Hazardous’ Symptom of BPD?

Recent research suggests that the atypical antipsychotic cariprazine may play a potential role in treating anxiety, which is a commonly overlooked symptom in bipolar I disorder. The drug does not have typical metabolic side effects seen with other medications in its class, making it a promising treatment for anxiety in patients with bipolar disorder. A…

Read More

Ensure Dental Health And Freshness

Proper oral hygiene is essential for overall health, and toothpaste plays a crucial role in maintaining dental health. While the Canadian Dental Association recommends using a pea-sized amount for adults, the best toothpaste for you depends on your individual needs and preferences. Some popular options include Crest Pro-Health Advanced Gum Protection, Colgate Total Clean Mint,…

Read More

GSK vaccine Arexvy accepted for regulatory review by EMA for adults aged 50-59 at increased risk for RSV

The GSK vaccine Arexvy has been accepted for regulatory review by the European Medicines Agency (EMA) for use in adults aged 50-59 who are at increased risk for respiratory syncytial virus (RSV). This vaccine is being considered for approval to protect this at-risk population from RSV. Additionally, the website uses cookies for analytics, advertising, and…

Read More

Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs

Altos Neuroscience is bringing precision medicine to psychiatric drug research with its technology, which analyzes biomarkers to match patients with the most effective treatments for neuropsychiatric disorders. The company’s recent IPO has raised $128.6 million, with shares trading on the New York Stock Exchange. Founded in 2019 by Stanford psychiatry professor Amit Etkin, the company’s…

Read More

Patients Are Twice as Likely to Quit Smoking with Cytisine

Cytisine, a potential drug therapy for smoking cessation, was found to double the chances of successful smoking cessation compared to placebo in a study published in Addiction. Researchers conducted a systematic review and meta-analysis of 12 randomized controlled trials (RCTs) comparing cytisine with placebo, nicotine replacement therapy (NRT), and varenicline alongside behavioral therapies for smoking…

Read More

AION Labs launches new startup using AI to discover molecular glue therapies

AION Labs, an AI-enabled drug discovery partnership, has launched a new startup called TenAces. TenAces will use AI to discover molecular glue therapies to enhance targeted protein degradation, potentially treating cancer and neurodegenerative diseases. The company will integrate biology into its machine learning algorithms and work with pharma partners to develop and commercialize solutions. AION…

Read More
error: Content is protected !!